APA (7th ed.) Citation

PV, S., A, K., N, M., S, K., G, C., S, F., & S, R. (2025). Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent. Biomolecules, 15(6), . https://doi.org/10.3390/biom15060805

Chicago Style (17th ed.) Citation

PV, Shekar, Kumar A, Mulgaonkar N, Kashyap S, Choudhir G, Fernando S, and Rustgi S. "Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent." Biomolecules 15, no. 6 (2025). https://doi.org/10.3390/biom15060805.

MLA (9th ed.) Citation

PV, Shekar, et al. "Aptamer Development for SARS-CoV-2 and Omicron Variants Using the Spike Protein Receptor Binding Domain as a Potential Diagnostic Tool and Therapeutic Agent." Biomolecules, vol. 15, no. 6, 2025, https://doi.org/10.3390/biom15060805.